Apigenin Market Size & Share 2023 to 2032
Market Size by Type (0.95, 0.98), by Application (Pharma and Healthcare, Food Additives, Cosmetic and Skin Care), by Region & Global Forecast.
Report ID: GMI6008
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Kiran Pulidindi, Kunal Ahuja
Apigenin Market Size
Apigenin Market size reached USD 300 thousand in 2022 and is estimated to grow at over 3.8% CAGR between 2023 and 2032. The market for natural and plant-based ingredients is witnessing significant growth as consumers increasingly seek healthier and more sustainable options. The rising demand for natural and plant-based products in industries such as pharmaceuticals, cosmetics, and food and beverages will stimulate business development.
Apigenin Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
As consumers become more health-conscious and seek natural remedies and supplements, the awareness and demand for apigenin as a dietary supplement or ingredient in functional foods and beverages are increasing. The growing body of research supporting the health benefits of apigenin is driving market growth.
One pitfall for the apigenin market could be the limited availability and extraction challenges. Although apigenin is naturally present in several plant sources, extracting it in large quantities can be challenging and costly. The limited availability and extraction difficulties may result in potential supply constraints, leading to fluctuations in pricing and availability of apigenin. Moreover, the reliance on specific plant sources for apigenin extraction raises concerns about sustainability and potential environmental impacts, necessitating careful management and alternative sourcing strategies to mitigate these challenges.
COVID-19 Impact
The pandemic has heightened global awareness of health and wellness, leading to an increased demand for natural and plant-based ingredients with potential health benefits. As a result, the apigenin market has showcased a surge in demand, particularly in the pharmaceutical and dietary supplement sectors. The focus on immunity-boosting and preventive healthcare has propelled the interest in natural compounds like apigenin, contributing to market growth. The pandemic has caused disruptions in global supply chains, including those for raw materials and ingredients. This disruption has affected the availability of apigenin from certain plant sources, leading to challenges in sourcing and production. Supply chain disruptions and logistical constraints have resulted in potential delays and increased costs, impacting the apigenin demand.
Apigenin Market Trends
Apigenin has been studied extensively for its potential therapeutic properties, including antioxidant, anti-inflammatory, anti-cancer, and neuroprotective effects. This has led to increased interest in utilizing apigenin in the development of pharmaceutical drugs and nutraceutical products. As research on apigenin continues to advance, the identification of new therapeutic applications and formulations is likely to influence the market growth. There is a significant emphasis on research and development activities within the apigenin business. As the understanding of apigenin's properties and potential applications expands, there is a continuous effort to explore its efficacy, safety, and interactions. Research initiatives are aimed at discovering novel uses, optimizing extraction methods, and enhancing the bioavailability of apigenin.
Apigenin Market Analysis
Based on type, the apigenin market is segmented as 0.95, 0.98 & Others. The 0.95 type segment accounted for USD 182.1 thousand in 2022 and is slated to exhibit more than 4% CAGR up to 2032. A 0.95 purity level indicates a high-quality product with a standardized concentration of apigenin. This level of purity ensures consistency and reliability in terms of the active compound content, which is crucial for research, formulation, and product development. In scientific research and pharmaceutical applications, it is often desirable to have a well-defined and concentrated form of apigenin. Researchers require precise control over the dosage and composition of the compound to study its effects and potential applications. A higher purity level allows for more accurate experimentation and analysis.
Based on application, the Apigenin market is segmented as pharma & healthcare, food additives, cosmetic & skin care, and others. In 2022 pharma & healthcare held majority market value of USD 127.2 thousand and is predicted to surpass 191.2 thousand by 2032. Apigenin has been extensively studied for its potential therapeutic properties, including its antioxidant, anti-inflammatory, anticancer, neuroprotective, and antimicrobial effects. These properties make apigenin a valuable compound for pharmaceutical applications.
The pharmaceutical industry utilizes apigenin in the development of drugs, supplements, and therapies for various health conditions, such as cancer, inflammation-related disorders, and neurodegenerative diseases. Apigenin, a naturally occurring flavonoid compound, is utilized in the food industry as a food additive for various purposes including as a flavoring agent, antioxidant, and colorant. Food Additives Market size valued at USD 100 billion in 2022 and is projected to register 7% CAGR from 2023 to 2032.
North America Apigenin market revenue crossed USD 144.1 thousand In 2022 and is expected to reach USD 209.7 thousand by 2032. North America has witnessed a rising demand for natural and plant-based ingredients in various industries, including pharmaceuticals, nutraceuticals, and cosmetics. Consumers are increasingly conscious of their health and seek products derived from natural sources. Apigenin, being a natural compound found in plants, aligns well with this consumer preference, driving its demand in the market.
North America has a well-established regulatory framework for the pharmaceutical and nutraceutical industries. The region's regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, provide guidelines and approvals for the use of natural compounds like apigenin in various applications. This supportive regulatory environment business statistics by ensuring safety, quality, and compliance with industry standards.
Apigenin Market Share
Notable players in the apigenin market are :
These companies are actively engaged in the production, distribution, and research of apigenin, positioning themselves as leading contributors to the market.
Apigenin Industry News:
This apigenin market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Tons and revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type
By Application
By Region
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →